Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisLorena Lorefice, Eleonora Cocco|Frontiers in Genetics|2023Cited by 16
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Ralph H. B. Benedict, Dejan Jakimovski et al.|NeuroImage Clinical|2024Cited by 13